HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM SEARCH

Clinical Trials for Mesothelioma Patients: Pazopanib

Read about a current clinical trial being conducted to study the effects of Pazopanib for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Rationale and Purpose

Pazopanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. This phase II trial is studying the side effects and how well Pazopanib works in treating patients with malignant pleural mesothelioma.

Objectives

Primary

• Determine the effect of Pazopanib hydrochloride on the proportion of patients with malignant pleural mesothelioma who are progression-free at 6 months based on the RECIST criteria.

• Determine the clinical toxicities of this drug in this patient population.

Secondary

• Determine the objective tumor response status in these patients as measured by the RECIST criteria or the modified RECIST criteria.

• Determine the response rate in patients treated with this drug.

• Determine the effect of this drug on overall survival and time to progression in these patients.

• Assess predictive markers of activity of this drug in these patients.

• Assess serologic markers of target inhibition by this drug in these patients.

Outline: This is a multicenter study. Patients receive oral Pazopanib hydrochloride once daily on days 1-21. Treatment repeats every 21 days for 2 years in the absence of disease progression or unacceptable toxicity. Blood is collected at baseline and prior to each course of therapy and analyzed for markers of angiogenesis. After completion of study therapy, patients are followed every 3 months.

Courtesy of ClinicalTrials.gov.

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

CONTACT WEITZ & LUXENBERG FOR A FREE LEGAL EVALUATION OF YOUR CASE

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Antineoplaston therapy for mesothelioma patients
AZD2171 therapy for mesothelioma patients
Current Bortezomib therapy for mesothelioma
Current Dasatinib therapy for mesothelioma
NSC 732517 trial description for mesothelioma
Cisplatin therapy for mesothelioma patients
Current Imatinib therapy for mesothelioma patients
Current Immunotoxin therapy: mesothelioma patients
Early mesothelioma symptoms from Canada asbestos
Canada study criteria of early mesothelioma traits
Contact info for mesothelioma program in Canada
Cisplatin and Pemetrexed therapy for mesothelioma
Description of Pemetrexed mesothelioma study
Inclusion standard in Pemetrexed mesothelioma test
Exclusion standard in Pemetrexed mesothelioma test
Contact info for Pemetrexed mesothelioma study
NGR for mesothelioma
NGR drug trials against mesothelioma
NGR for mesothelioma study
Exclusion criteria for mesothelioma NGR study
Contact for Antineoplaston test on mesothelioma
Pazopanib for mesothelioma patients
Pazopanib for mesothelioma study
Pazopanib inclusion criteria at mesothelioma trial
Patient criteria for mesothelioma Pazopanib study
Pazopanib for mesothelioma therapy
Pemetrexed drug for mesothelioma patients
Pemetrexed drug study for mesothelioma patients
Pemetrexed and cisplatin for mesothelioma patients
Pemetrexed study outline for mesothelioma patients
Pemetrexed disodium drug trial for mesothelioma
Pemetrexed trials for mesothelioma patients
Pemetrexed trials for mesothelioma patients
Contact info: Pemetrexed trial for mesothelioma
Vitamin B12 test on mesothelioma patients
Vitamin B12 study on mesothelioma patients
Outcome of Vitamin B12 on mesothelioma patients
Vitamin B12 outline for mesothelioma study
Patient criteria for B12 study on mesothelioma
Criteria of Vitamin B12 therapy on mesothelioma
Contact info of mesothelioma clinical trial of B12
Novartis LBH589 for mesothelioma
Novartis LBH589 for mesothelioma study
LBH589 trial for mesothelioma
Clinical LBH589 for mesothelioma
Clinical trial for esophageal cancer, mesothelioma
Clinical trial of hTNF for mesothelioma
Valproate for Mesothelioma
Vandetanib tested for mesothelioma
Vorinostat tested for mesothelioma
Avastin therapy for mesothelioma
Carboplatin for MPM mesothelioma patients
Decitabine for mesothelioma
Intravenous CRS-207 for mesothelioma
Sorafenib study on mesothelioma patients
SU011248 for mesothelioma
Temo-Azac combo for mesothelioma
Mesothelioma vaccine GM-CSF


RETURN BACK TO
Mesothelioma
Symptoms, Stages, Treatment of Mesothelioma
Treatment
see also:

Pazopanib for mesothelioma study Clinical trial to study Pazopanib drug on mesothelioma patients
New study tests effect of Pazopanib drug on mesothelioma patients

Current Imatinib therapy for mesothelioma patients Current clinical trial of Imatinib therapy for mesothelioma patients
Imatinib may inhibit cancer cell growth in current mesothelioma test

Clinical trials on asbestos illness: mesothelioma Info about clinical trials on mesothelioma, an asbestos illness
Information on clinical trials of the asbestos illness, mesothelioma